Patterns of pelvic radiotherapy in patients with stage II/III rectal cancer

Journal of Cancer Epidemiology

Volumn 2013, Issue , 2013, Pages

  Fitzgerald, Timothy L ^a,b,c   Zervos, Emmanuel ^a,b,c   Wong, Jan H ^a,b,c  

^a Leo Jenkins Cancer Center   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; RECTUM CANCER; SEX DIFFERENCE; SOCIAL ASPECT; SOCIAL STATUS;

EID: 84886674030     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2013/408460     Document Type: Article

References (36)

1. Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Mailliard J. A., Twito D. I., Morton R. F., Veeder M. H., Witzig T. E., Cha S., Vidyarthi C., Effective surgical adjuvant therapy for high-risk rectal carcinoma. The New England Journal of Medicine 1991 324 11 709 715 2-s2.0-0026071185
2. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. The Journal of the American Medical Association 1990 264 11 1444 1450 2-s2.0-0025710611 10.1001/jama.264.11.1444 (Pubitemid 20331943)
3. Roos M., Wong J. H., Roy-Chowdhury S., Lum S. S., Morgan J. W., Kazanjian K., The impact of multidisciplinary therapy in node-positive rectal cancer. The American Surgeon 2010 76 10 1163 1166 2-s2.0-78651356137
4. Kuo I., Wong J. H., Roy-Chowdhury S., Lum S. S., Morgan J. W., Kazanjian K., The use of pelvic radiation in stage II rectal cancer: a population-based analysis. The American Surgeon 2010 76 10 1092 1095 2-s2.0-78651356139
5. Jullumstrø E., Wibe A., Lydersen S., Edna T. H., Violation of treatment guidelines-hazard for rectal cancer patients. International Journal of Colorectal Disease 2012 27 1 103 109 2-s2.0-84857061029 10.1007/s00384-011- 1283-8
6. Fitzgerald T. L., Biswas T., O'Brien K., Zervos E. E., Wong J. H., Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice. World Journal of Surgery 2013 37 3 639 645
7. Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England Journal of Medicine 1997 336 14 980 987 2-s2.0-1842377447 10.1056/NEJM199704033361402 (Pubitemid 27152783)
8. Sauer R., Becker H., Hohenberger W., Rödel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C. F., Karstens J.-H., Liersch T., Schmidberger H., Raab R., Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England Journal of Medicine 2004 351 17 1731 1740 2-s2.0-6044226542 10.1056/NEJMoa040694 (Pubitemid 39383208)
9. Sauer R., Liersch T., Merkel S., Fietkau R., Hohenberger W., Hess C., Becker H., Raab H. R., Villanueva M. T., Witzigmann H., Wittekind C., Beissbarth T., Rödel C., Preoperative versus postoperative chemoradiotherapy forlocally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. Journal of Clinical Oncology 2012 30 16 1926 1933
10. Benson A. B. III, Bekaii-Saab T., Chan E., Rectal cancer. Journal of the National Comprehensive Cancer Network 2012 10 12 1528 1564
11. Fitzgerald T. L., Biswas T., O'Brien K., Zervos E. E., Wong J. H., Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice. World Journal of Surgery 2013 37 3 639 645
12. Fitzgerald T. L., Bradley C. J., Dahman B., Zervos E. E., Gastrointestinal malignancies: when does race matter? Journal of the American College of Surgeons 2009 209 5 645 652 2-s2.0-70350134187 10.1016/j.jamcollsurg. 2009.08.007
13. Bradley C. J., Given C. W., Dahman B., Fitzgerald T. L., Adjuvant chemotherapy after resection in elderly medicare and medicaid patients with colon cancer. Archives of Internal Medicine 2008 168 5 521 529 2-s2.0-41949085158 10.1001/archinternmed.2007.82 (Pubitemid 351547216)
14. Robert S. A., Strombom I., Trentham-Dietz A., Hampton J. M., McElroy J. A., Newcomb P. A., Remington P. L., Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology 2004 15 4 442 450 2-s2.0-4344678791 10.1097/01.ede.0000129512.61698.03 (Pubitemid 40416932)
15. Tougeron D., Roullet B., Paillot B., Hamidou H., Tourani J.-M., Bensadoun R.-J., Michel P., Silvain C., Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two french tertiary centres. Digestive and Liver Disease 2012 44 4 350 354 2-s2.0-84857649723 10.1016/j.dld.2011.10.017
16. Quipourt V., Jooste V., Cottet V., Faivre J., Bouvier A. M., Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study. Journal of the American Geriatrics Society 2011 59 4 694 698 2-s2.0-79954723185 10.1111/j.1532-5415. 2011.03334.x
17. Margalit D. N., Mamon H. J., Ancukiewicz M., Kobayashi W., Ryan D. P., Blaszkowsky L. S., Clark J., Willett C. G., Hong T. S., Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. International Journal of Radiation Oncology Biology Physics 2011 81 5 e735 e741 2-s2.0-79956359847 10.1016/j.ijrobp.2010.12.056
18. Zuckerman I. H., Rapp T., Onukwugha E., Davidoff A., Choti M. A., Gardner J., Seal B., Mullins C. D., Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer. Journal of the American Geriatrics Society 2009 57 8 1403 1410 2-s2.0-68149145498 10.1111/j.1532-5415.2009.02355.x
19. Fata F., Mirza A., Wood G. C., Nair S., Law A., Gallagher J., Ellison N., Bernath A., Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger medical center. Cancer 2002 94 7 1931 1938 2-s2.0-0036534110 10.1002/cncr.10430 (Pubitemid 34270045)
20. Sundararajan V., Mitra N., Jacobson J. S., Grann V. R., Heitjan D. F., Neugut A. I., Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Annals of Internal Medicine 2002 136 5 349 357 2-s2.0-0037022820 (Pubitemid 34183993)
21. Elferink M. A., Krijnen P., Wouters M. W., Lemmens V. E. P. P., Jansen-Landheer M. L. E. A., van de Velde C. J. H., Langendijk J. A., Marijnen C. A. M., Siesling S., Tollenaar R. A. E. M., Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. European Journal of Surgical Oncology 2010 36 supplement 1 S74 S82 2-s2.0-77955653375 10.1016/j.ejso.2010.06.028
22. Cronin D. P., Harlan L. C., Potosky A. L., Clegg L. X., Stevens J. L., Mooney M. M., Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. The American Journal of Gastroenterology 2006 101 10 2308 2318 2-s2.0-33749161222 10.1111/j.1572-0241. 2006.00775.x (Pubitemid 44477559)
23. Cree M., Tonita J., Turner D., Nugent Z., Alvi R., Barss R., King C., Winget M., Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Clinical Colorectal Cancer 2009 8 3 141 145 2-s2.0-69549085138 10.3816/CCC.2009.n.023
24. Sankaranarayanan J., Watanabe-Galloway S., Sun J., Qiu F., Boilesen E. C., Thorson A. G., Age and rural residence effects on accessing colorectal cancer treatments: a registry study. The American Journal of Managed Care 2010 16 4 265 273 2-s2.0-77951589730
25. Milburn Jessup J., Stewart A., Greene F. L., Minsky B. D., Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. The Journal of the American Medical Association 2005 294 21 2703 2711 2-s2.0-28844482345 10.1001/jama.294.21.2703 (Pubitemid 41770099)
26. Saldana-Ruiz N., Clouston S. A., Rubin M. S., Colen C. G., Link B. G., Fundamental causes of colorectal cancer mortality in the United States: understanding the importance of socioeconomic status in creating inequality in mortality. The American Journal of Public Health 2013 103 1 99 104
27. Winget M., Hossain S., Yasui Y., Scarfe A., Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Cancer 2010 116 20 4849 4856 2-s2.0-78349255362 10.1002/cncr.25250
28. Zhu J., Xu Y., Gu W., Peng J., Cai G., Cai G., Sun W., Shen W., Cai S., Zhang Z., Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era-identification of the high risk patients. Radiation Oncology 2010 5 1, article 118 2-s2.0-78650048367 10.1186/1748-717X-5-118
29. Engstrom P. F., Arnoletti J. P. III, Benson A. B., NCCN clinical practice guidelines in oncology: rectal cancer. Journal of the National Comprehensive Cancer Network 2009 7 8 838 881
30. Köckerling F., Reymond M. A., Altendorf-Hofmann A., Dworak O., Hohenberger W., Influence of surgery on metachronous distant metastases and survival in rectal cancer. Journal of Clinical Oncology 1998 16 1 324 329 2-s2.0-0343573267 (Pubitemid 28041616)
31. Eldin N. S., Yasui Y., Scarfe A., Winget M., Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clinical Oncology 2012 24 1 e9 e17 2-s2.0-84455199754 10.1016/j.clon.2011.07.005
32. Phang P. T., Woods R., Brown C. J., Raval M., Cheifetz R., Kennecke H., Effect of systematic education courses on rectal cancer treatments in a population. The American Journal of Surgery 2011 201 5 640 644 2-s2.0-79955676105 10.1016/j.amjsurg.2011.01.008
33. den Dulk M., Krijnen P., Marijnen C. A. M., Rutten H. J., van de Poll-Franse L. V., Putter H., Meershoek-Klein Kranenbarg E., Jansen-Landheer M. L. E. A., Coebergh J. W. W., van de Velde C. J. H., Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. European Journal of Cancer 2008 44 12 1710 1716 2-s2.0-48449101049 10.1016/j.ejca.2008.05.004
34. Phang P. T., Evolving rectal cancer management in British Columbia. Canadian Journal of Surgery 2010 53 4 222 224 2-s2.0-77955391403
35. Overgaard M., Hansen P. S., Overgaard J., Rose C., Andersson M., Bach F., Kjaer M., Gadeberg C. C., Mouridsen H. T., Jensen M. B., Zedeler K., Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. The New England Journal of Medicine 1997 337 14 949 955 2-s2.0-9844227910 10.1056/NEJM199710023371401 (Pubitemid 27425950)
36. Ragaz J., Olivotto I. A., Spinelli J. J., Phillips N., Jackson S. M., Wilson K. S., Knowling M. A., Coppin C. M., Weir L., Gelmon K., Le N., Durand R., Coldman A. J., Manji M., Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Journal of the National Cancer Institute 2005 97 2 116 126 2-s2.0-23244458297 10.1093/jnci/dji216 (Pubitemid 41511217)